ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Major adverse cardiac events and drug-coated balloon size in coronary interventions [Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(6): 382-387 | DOI: 10.14744/AnatolJCardiol.2018.67864

Major adverse cardiac events and drug-coated balloon size in coronary interventions

David Naguib, Betül Knoop, Lisa Dannenberg, Eva Liebsch, Martin Pöhl, Carolin Helten, Athena Assadi-schmidt, Malte Kelm, Tobias Zeus, Amin Polzin
Division of Cardiology, Pulmonology, and Vascular Medicine, Heinrich Heine University Medical Center Düsseldorf; Düsseldorf-Germany

Objective: In-stent restenosis (ISR) is a feared complication after coronary stent implantation. Drug-coated balloon (DCB) is being promoted as a treatment option for ISR. However, the benefit-risk ratio of DCB length has not been investigated. Longer DCBs release more anti-proliferative drug to the vessel wall; however, they are associated with a higher lesion length and vessel injury. Hypothesis: DCB length is associated with clinical outcome.
Methods: We analyzed 286 consecutive Pantera Lux (Biotronik, active component Paclitaxel) DCB-treated patients between April 2009 and June 2012. Of them, 176 patients were treated using a 15-mm DCB and 109 were treated using a 20-mm DCB. Baseline characteristics and major adverse cardiac events (MACE; death, myocardial infarction, and target lesion revascularization) during initial hospital stay and a 2-year follow-up period were obtained.
Results: Patients characteristics such as cardiovascular risk factors, prior diseases, co-medication, clinical presentation, target vessel, and left ventricular function did not differ between the groups. MACE during hospital course was similar [1.7% vs. 2.8%, relative risk (RR) 1.6, 95% confidence interval (CI) 0.3-7.9, p=0.554]. Likewise, at 2-year follow-up, MACE did not differ between the groups (23.2% vs. 27.5%, RR 1.2, 95% CI 0.6-1.5, p=0.408).
Conclusion: DCB length was not associated with clinical outcome during a 2-year follow-up period.

Keywords: drug-coated balloon, drug-eluting stent, MACE, paclitaxel

David Naguib, Betül Knoop, Lisa Dannenberg, Eva Liebsch, Martin Pöhl, Carolin Helten, Athena Assadi-schmidt, Malte Kelm, Tobias Zeus, Amin Polzin. Major adverse cardiac events and drug-coated balloon size in coronary interventions. Anatol J Cardiol. 2018; 19(6): 382-387

Corresponding Author: Lisa Dannenberg, Germany
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.